EP1454127A1 - Optically transparent substrate for a maldi measuring system and the use thereof - Google Patents
Optically transparent substrate for a maldi measuring system and the use thereofInfo
- Publication number
- EP1454127A1 EP1454127A1 EP02804574A EP02804574A EP1454127A1 EP 1454127 A1 EP1454127 A1 EP 1454127A1 EP 02804574 A EP02804574 A EP 02804574A EP 02804574 A EP02804574 A EP 02804574A EP 1454127 A1 EP1454127 A1 EP 1454127A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- carrier substrate
- optically transparent
- layer
- maldi
- analytes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000758 substrate Substances 0.000 title claims abstract description 195
- 238000001514 detection method Methods 0.000 claims abstract description 196
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 claims abstract description 123
- 230000003287 optical effect Effects 0.000 claims abstract description 108
- 238000005259 measurement Methods 0.000 claims abstract description 45
- 229910044991 metal oxide Inorganic materials 0.000 claims abstract description 29
- 150000004706 metal oxides Chemical group 0.000 claims abstract description 29
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 17
- 239000010410 layer Substances 0.000 claims description 139
- 239000012491 analyte Substances 0.000 claims description 99
- -1 alkyl phosphates Chemical class 0.000 claims description 73
- 239000011159 matrix material Substances 0.000 claims description 71
- 230000005284 excitation Effects 0.000 claims description 67
- 238000000034 method Methods 0.000 claims description 58
- 230000008878 coupling Effects 0.000 claims description 51
- 238000010168 coupling process Methods 0.000 claims description 51
- 238000005859 coupling reaction Methods 0.000 claims description 51
- 238000004020 luminiscence type Methods 0.000 claims description 48
- 238000004949 mass spectrometry Methods 0.000 claims description 40
- 230000027455 binding Effects 0.000 claims description 36
- 108090000623 proteins and genes Proteins 0.000 claims description 32
- 102000004169 proteins and genes Human genes 0.000 claims description 31
- 235000018102 proteins Nutrition 0.000 claims description 29
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 claims description 28
- 229930013930 alkaloid Natural products 0.000 claims description 27
- 239000000126 substance Substances 0.000 claims description 24
- 230000008859 change Effects 0.000 claims description 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 19
- 108020004414 DNA Proteins 0.000 claims description 17
- 150000007523 nucleic acids Chemical class 0.000 claims description 17
- 239000011521 glass Substances 0.000 claims description 16
- 102000039446 nucleic acids Human genes 0.000 claims description 16
- 108020004707 nucleic acids Proteins 0.000 claims description 16
- 229930182470 glycoside Natural products 0.000 claims description 15
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 claims description 15
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 14
- 229940111121 antirheumatic drug quinolines Drugs 0.000 claims description 14
- 229940098773 bovine serum albumin Drugs 0.000 claims description 14
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims description 14
- 229920000570 polyether Polymers 0.000 claims description 14
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 claims description 14
- 150000003248 quinolines Chemical class 0.000 claims description 14
- 229910010413 TiO 2 Inorganic materials 0.000 claims description 13
- 229930003935 flavonoid Natural products 0.000 claims description 13
- 150000002215 flavonoids Chemical class 0.000 claims description 13
- 235000017173 flavonoids Nutrition 0.000 claims description 13
- 150000002596 lactones Chemical class 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 150000002475 indoles Chemical class 0.000 claims description 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 12
- 230000001133 acceleration Effects 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- 150000002500 ions Chemical class 0.000 claims description 11
- 229920003023 plastic Polymers 0.000 claims description 11
- 108010069514 Cyclic Peptides Proteins 0.000 claims description 10
- 102000001189 Cyclic Peptides Human genes 0.000 claims description 10
- 239000000427 antigen Substances 0.000 claims description 10
- 108091007433 antigens Proteins 0.000 claims description 10
- 102000036639 antigens Human genes 0.000 claims description 10
- 238000003795 desorption Methods 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 10
- 108091034117 Oligonucleotide Proteins 0.000 claims description 9
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 9
- 238000003556 assay Methods 0.000 claims description 9
- 235000014633 carbohydrates Nutrition 0.000 claims description 9
- 150000001720 carbohydrates Chemical class 0.000 claims description 9
- 238000004332 deodorization Methods 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 claims description 8
- 108090001090 Lectins Proteins 0.000 claims description 8
- 102000004856 Lectins Human genes 0.000 claims description 8
- 150000001789 chalcones Chemical class 0.000 claims description 8
- 235000005513 chalcones Nutrition 0.000 claims description 8
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 8
- 239000002523 lectin Substances 0.000 claims description 8
- 239000003446 ligand Substances 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 8
- 108020003175 receptors Proteins 0.000 claims description 8
- 102000005962 receptors Human genes 0.000 claims description 8
- 238000011160 research Methods 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 claims description 7
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 claims description 7
- 229930192627 Naphthoquinone Chemical class 0.000 claims description 7
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 7
- 229920002472 Starch Chemical class 0.000 claims description 7
- 229930182558 Sterol Natural products 0.000 claims description 7
- 150000000475 acetylene derivatives Chemical class 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 235000010443 alginic acid Nutrition 0.000 claims description 7
- 229920000615 alginic acid Polymers 0.000 claims description 7
- 150000004781 alginic acids Chemical class 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 7
- 239000003242 anti bacterial agent Substances 0.000 claims description 7
- 229940088710 antibiotic agent Drugs 0.000 claims description 7
- 239000012965 benzophenone Chemical class 0.000 claims description 7
- 150000008366 benzophenones Chemical class 0.000 claims description 7
- 239000003613 bile acid Substances 0.000 claims description 7
- 150000001738 cardenolides Chemical class 0.000 claims description 7
- 239000001913 cellulose Chemical class 0.000 claims description 7
- 235000010980 cellulose Nutrition 0.000 claims description 7
- 229920002678 cellulose Chemical class 0.000 claims description 7
- 150000001907 coumarones Chemical class 0.000 claims description 7
- 238000009826 distribution Methods 0.000 claims description 7
- NBIQERZFHYWUCH-UHFFFAOYSA-N furo[2,3-h]quinoline Chemical class C1=CN=C2C(C=CO3)=C3C=CC2=C1 NBIQERZFHYWUCH-UHFFFAOYSA-N 0.000 claims description 7
- 150000002338 glycosides Chemical class 0.000 claims description 7
- 150000002460 imidazoles Chemical class 0.000 claims description 7
- 150000002537 isoquinolines Chemical class 0.000 claims description 7
- 150000002791 naphthoquinones Chemical class 0.000 claims description 7
- 150000002989 phenols Chemical class 0.000 claims description 7
- 150000003212 purines Chemical class 0.000 claims description 7
- 150000003222 pyridines Chemical class 0.000 claims description 7
- 229940079877 pyrogallol Drugs 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 7
- 239000008107 starch Chemical class 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 150000003431 steroids Chemical class 0.000 claims description 7
- 235000003702 sterols Nutrition 0.000 claims description 7
- 235000000346 sugar Nutrition 0.000 claims description 7
- 229920001864 tannin Polymers 0.000 claims description 7
- 239000001648 tannin Substances 0.000 claims description 7
- 235000018553 tannin Nutrition 0.000 claims description 7
- 239000010409 thin film Substances 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000000341 volatile oil Substances 0.000 claims description 7
- 150000007964 xanthones Chemical class 0.000 claims description 7
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 6
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 6
- 102000015636 Oligopeptides Human genes 0.000 claims description 6
- 108010038807 Oligopeptides Proteins 0.000 claims description 6
- 238000012356 Product development Methods 0.000 claims description 6
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims description 6
- 230000009918 complex formation Effects 0.000 claims description 6
- 235000001671 coumarin Nutrition 0.000 claims description 6
- 125000000332 coumarinyl group Chemical class O1C(=O)C(=CC2=CC=CC=C12)* 0.000 claims description 6
- 230000008021 deposition Effects 0.000 claims description 6
- GBHRVZIGDIUCJB-UHFFFAOYSA-N hydrogenphosphite Chemical class OP([O-])[O-] GBHRVZIGDIUCJB-UHFFFAOYSA-N 0.000 claims description 6
- RTRZOHKLISMNRD-UHFFFAOYSA-N isoflavanone Chemical class C1OC2=CC=CC=C2C(=O)C1C1=CC=CC=C1 RTRZOHKLISMNRD-UHFFFAOYSA-N 0.000 claims description 6
- 239000003120 macrolide antibiotic agent Substances 0.000 claims description 6
- 239000013307 optical fiber Substances 0.000 claims description 6
- 244000052769 pathogen Species 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 239000013545 self-assembled monolayer Substances 0.000 claims description 6
- 239000003270 steroid hormone Substances 0.000 claims description 6
- 150000003432 sterols Chemical class 0.000 claims description 6
- 210000001519 tissue Anatomy 0.000 claims description 6
- 239000001993 wax Substances 0.000 claims description 6
- 108010002156 Depsipeptides Proteins 0.000 claims description 5
- 239000004793 Polystyrene Substances 0.000 claims description 5
- 108010090804 Streptavidin Proteins 0.000 claims description 5
- 150000007513 acids Chemical class 0.000 claims description 5
- 239000012790 adhesive layer Substances 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 claims description 5
- 239000000539 dimer Substances 0.000 claims description 5
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 claims description 5
- 229930003944 flavone Natural products 0.000 claims description 5
- 150000002213 flavones Chemical class 0.000 claims description 5
- 235000011949 flavones Nutrition 0.000 claims description 5
- 238000013537 high throughput screening Methods 0.000 claims description 5
- 150000002632 lipids Chemical class 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 229940041033 macrolides Drugs 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 150000002978 peroxides Chemical class 0.000 claims description 5
- 239000004033 plastic Substances 0.000 claims description 5
- 229920001184 polypeptide Polymers 0.000 claims description 5
- 229920002223 polystyrene Polymers 0.000 claims description 5
- 150000003233 pyrroles Chemical class 0.000 claims description 5
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 claims description 4
- BRARRAHGNDUELT-UHFFFAOYSA-N 3-hydroxypicolinic acid Chemical compound OC(=O)C1=NC=CC=C1O BRARRAHGNDUELT-UHFFFAOYSA-N 0.000 claims description 4
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methoxysalicylic acid Chemical compound COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 claims description 4
- 108091023037 Aptamer Proteins 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 4
- 102000002068 Glycopeptides Human genes 0.000 claims description 4
- 108010015899 Glycopeptides Proteins 0.000 claims description 4
- 102000003886 Glycoproteins Human genes 0.000 claims description 4
- 108090000288 Glycoproteins Proteins 0.000 claims description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 4
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 claims description 4
- 230000031018 biological processes and functions Effects 0.000 claims description 4
- 229960002685 biotin Drugs 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 239000002738 chelating agent Substances 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 4
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 239000003112 inhibitor Substances 0.000 claims description 4
- JVTZFYYHCGSXJV-UHFFFAOYSA-N isovanillin Chemical compound COC1=CC=C(C=O)C=C1O JVTZFYYHCGSXJV-UHFFFAOYSA-N 0.000 claims description 4
- 150000001247 metal acetylides Chemical class 0.000 claims description 4
- 150000002739 metals Chemical class 0.000 claims description 4
- 150000004767 nitrides Chemical class 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 229940127557 pharmaceutical product Drugs 0.000 claims description 4
- 235000021317 phosphate Nutrition 0.000 claims description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 4
- 239000004417 polycarbonate Substances 0.000 claims description 4
- 229920000515 polycarbonate Polymers 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 108091033319 polynucleotide Proteins 0.000 claims description 4
- 102000040430 polynucleotide Human genes 0.000 claims description 4
- 239000002157 polynucleotide Substances 0.000 claims description 4
- 229930010796 primary metabolite Natural products 0.000 claims description 4
- 239000010453 quartz Substances 0.000 claims description 4
- 150000004053 quinones Chemical class 0.000 claims description 4
- 229930000044 secondary metabolite Natural products 0.000 claims description 4
- 239000002094 self assembled monolayer Substances 0.000 claims description 4
- 239000004065 semiconductor Substances 0.000 claims description 4
- 150000004756 silanes Chemical class 0.000 claims description 4
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 230000003595 spectral effect Effects 0.000 claims description 4
- 238000003786 synthesis reaction Methods 0.000 claims description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 229920006352 transparent thermoplastic Polymers 0.000 claims description 4
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 claims description 3
- 230000005540 biological transmission Effects 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 238000003384 imaging method Methods 0.000 claims description 3
- 230000009871 nonspecific binding Effects 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 2
- PLVPPLCLBIEYEA-AATRIKPKSA-N (E)-3-(indol-3-yl)acrylic acid Chemical compound C1=CC=C2C(/C=C/C(=O)O)=CNC2=C1 PLVPPLCLBIEYEA-AATRIKPKSA-N 0.000 claims description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 2
- XLEYFDVVXLMULC-UHFFFAOYSA-N 2',4',6'-trihydroxyacetophenone Chemical compound CC(=O)C1=C(O)C=C(O)C=C1O XLEYFDVVXLMULC-UHFFFAOYSA-N 0.000 claims description 2
- YPTJKHVBDCRKNF-UHFFFAOYSA-N 2',6'-Dihydroxyacetophenone Chemical compound CC(=O)C1=C(O)C=CC=C1O YPTJKHVBDCRKNF-UHFFFAOYSA-N 0.000 claims description 2
- WRRQHEMZOCFTQP-UHFFFAOYSA-N 2,2,2-trihydroxy-1-phenylethanone Chemical class OC(O)(O)C(=O)C1=CC=CC=C1 WRRQHEMZOCFTQP-UHFFFAOYSA-N 0.000 claims description 2
- AAUQLHHARJUJEH-UHFFFAOYSA-N 2-hydroxy-5-methoxybenzoic acid Natural products COC1=CC=CC(O)=C1C(O)=O AAUQLHHARJUJEH-UHFFFAOYSA-N 0.000 claims description 2
- SVNCRRZKBNSMIV-UHFFFAOYSA-N 3-Aminoquinoline Chemical compound C1=CC=CC2=CC(N)=CN=C21 SVNCRRZKBNSMIV-UHFFFAOYSA-N 0.000 claims description 2
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 claims description 2
- CDWGDLKZKCYUFO-UHFFFAOYSA-N 6-(trifluoromethyl)-1h-indole-2-carboxylic acid Chemical compound C1=C(C(F)(F)F)C=C2NC(C(=O)O)=CC2=C1 CDWGDLKZKCYUFO-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 2
- 108010088751 Albumins Proteins 0.000 claims description 2
- 102000009027 Albumins Human genes 0.000 claims description 2
- 241000972773 Aulopiformes Species 0.000 claims description 2
- 102000011632 Caseins Human genes 0.000 claims description 2
- 108010076119 Caseins Proteins 0.000 claims description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 2
- 241000252203 Clupea harengus Species 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 239000004593 Epoxy Substances 0.000 claims description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 2
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 2
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims description 2
- 239000004642 Polyimide Substances 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 102000029797 Prion Human genes 0.000 claims description 2
- 108091000054 Prion Proteins 0.000 claims description 2
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 claims description 2
- 241000607142 Salmonella Species 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims description 2
- 238000007259 addition reaction Methods 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims description 2
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 229920001400 block copolymer Polymers 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000001124 body fluid Anatomy 0.000 claims description 2
- 239000010839 body fluid Substances 0.000 claims description 2
- 230000001680 brushing effect Effects 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- 235000004883 caffeic acid Nutrition 0.000 claims description 2
- 229940074360 caffeic acid Drugs 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 230000021164 cell adhesion Effects 0.000 claims description 2
- 238000004113 cell culture Methods 0.000 claims description 2
- 239000000919 ceramic Substances 0.000 claims description 2
- 229930016911 cinnamic acid Natural products 0.000 claims description 2
- 235000013985 cinnamic acid Nutrition 0.000 claims description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 2
- 238000012875 competitive assay Methods 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- 238000007598 dipping method Methods 0.000 claims description 2
- 229960002311 dithranol Drugs 0.000 claims description 2
- 235000013345 egg yolk Nutrition 0.000 claims description 2
- 210000002969 egg yolk Anatomy 0.000 claims description 2
- 238000003891 environmental analysis Methods 0.000 claims description 2
- 239000003344 environmental pollutant Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 238000000695 excitation spectrum Methods 0.000 claims description 2
- 238000002284 excitation--emission spectrum Methods 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 2
- 235000001785 ferulic acid Nutrition 0.000 claims description 2
- 229940114124 ferulic acid Drugs 0.000 claims description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 238000004186 food analysis Methods 0.000 claims description 2
- 125000000524 functional group Chemical group 0.000 claims description 2
- 229940074391 gallic acid Drugs 0.000 claims description 2
- 235000004515 gallic acid Nutrition 0.000 claims description 2
- 229960005219 gentisic acid Drugs 0.000 claims description 2
- 235000019514 herring Nutrition 0.000 claims description 2
- 125000001072 heteroaryl group Chemical group 0.000 claims description 2
- 238000009396 hybridization Methods 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 150000005165 hydroxybenzoic acids Chemical class 0.000 claims description 2
- 238000003018 immunoassay Methods 0.000 claims description 2
- VDBNYAPERZTOOF-UHFFFAOYSA-N isoquinolin-1(2H)-one Chemical compound C1=CC=C2C(=O)NC=CC2=C1 VDBNYAPERZTOOF-UHFFFAOYSA-N 0.000 claims description 2
- 210000002751 lymph Anatomy 0.000 claims description 2
- 230000001404 mediated effect Effects 0.000 claims description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 2
- 238000000813 microcontact printing Methods 0.000 claims description 2
- 239000002105 nanoparticle Substances 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 150000002924 oxiranes Chemical class 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 claims description 2
- 229920006112 polar polymer Polymers 0.000 claims description 2
- 230000010287 polarization Effects 0.000 claims description 2
- 231100000719 pollutant Toxicity 0.000 claims description 2
- 229920000729 poly(L-lysine) polymer Polymers 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 229920001721 polyimide Polymers 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 238000012910 preclinical development Methods 0.000 claims description 2
- 229960000581 salicylamide Drugs 0.000 claims description 2
- 235000019515 salmon Nutrition 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- 150000004760 silicates Chemical class 0.000 claims description 2
- 239000002356 single layer Substances 0.000 claims description 2
- 239000002689 soil Substances 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 238000013517 stratification Methods 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 2
- 239000002352 surface water Substances 0.000 claims description 2
- 229940126585 therapeutic drug Drugs 0.000 claims description 2
- 150000003573 thiols Chemical class 0.000 claims description 2
- 231100000041 toxicology testing Toxicity 0.000 claims description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 2
- 229910000314 transition metal oxide Inorganic materials 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 claims description 2
- 229910052727 yttrium Inorganic materials 0.000 claims description 2
- AFVLVVWMAFSXCK-UHFFFAOYSA-N α-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(C#N)=CC1=CC=C(O)C=C1 AFVLVVWMAFSXCK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000783 alginic acid Substances 0.000 claims 3
- 229960001126 alginic acid Drugs 0.000 claims 3
- 229930190585 Saframycin Natural products 0.000 claims 2
- 230000000536 complexating effect Effects 0.000 claims 2
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 claims 2
- 239000003905 agrochemical Substances 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 238000010422 painting Methods 0.000 claims 1
- 238000004018 waxing Methods 0.000 claims 1
- 230000006698 induction Effects 0.000 abstract 2
- 239000000523 sample Substances 0.000 description 28
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 description 14
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 14
- PBCFLUZVCVVTBY-UHFFFAOYSA-N tantalum pentoxide Inorganic materials O=[Ta](=O)O[Ta](=O)=O PBCFLUZVCVVTBY-UHFFFAOYSA-N 0.000 description 14
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 11
- 229910052737 gold Inorganic materials 0.000 description 11
- 239000010931 gold Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 10
- 238000001819 mass spectrum Methods 0.000 description 10
- 239000000872 buffer Substances 0.000 description 7
- 238000001228 spectrum Methods 0.000 description 6
- 108010036176 Melitten Proteins 0.000 description 5
- 239000012876 carrier material Substances 0.000 description 5
- 239000010408 film Substances 0.000 description 5
- 238000002493 microarray Methods 0.000 description 5
- 238000013459 approach Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000001869 matrix assisted laser desorption--ionisation mass spectrum Methods 0.000 description 4
- 239000012047 saturated solution Substances 0.000 description 4
- 101001002709 Homo sapiens Interleukin-4 Proteins 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 102000055229 human IL4 Human genes 0.000 description 3
- 238000002161 passivation Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000000018 DNA microarray Methods 0.000 description 2
- 239000002318 adhesion promoter Substances 0.000 description 2
- 239000012131 assay buffer Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000102542 Kara Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229940028885 interleukin-4 Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000003368 label free method Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 238000002796 luminescence method Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000009149 molecular binding Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000002974 pharmacogenomic effect Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/02—Details
- H01J49/04—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components
- H01J49/0409—Sample holders or containers
- H01J49/0418—Sample holders or containers for laser desorption, e.g. matrix-assisted laser desorption/ionisation [MALDI] plates or surface enhanced laser desorption/ionisation [SELDI] plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/251—Colorimeters; Construction thereof
- G01N21/253—Colorimeters; Construction thereof for batch operation, i.e. multisample apparatus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/41—Refractivity; Phase-affecting properties, e.g. optical path length
- G01N21/45—Refractivity; Phase-affecting properties, e.g. optical path length using interferometric methods; using Schlieren methods
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/55—Specular reflectivity
- G01N21/552—Attenuated total reflection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/7703—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides
- G01N21/774—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides the reagent being on a grating or periodic structure
- G01N21/7743—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides the reagent being on a grating or periodic structure the reagent-coated grating coupling light in or out of the waveguide
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00364—Pipettes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00378—Piezoelectric or ink jet dispensers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00387—Applications using probes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00585—Parallel processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/0061—The surface being organic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00612—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00614—Delimitation of the attachment areas
- B01J2219/00617—Delimitation of the attachment areas by chemical means
- B01J2219/00619—Delimitation of the attachment areas by chemical means using hydrophilic or hydrophobic regions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00623—Immobilisation or binding
- B01J2219/0063—Other, e.g. van der Waals forces, hydrogen bonding
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00632—Introduction of reactive groups to the surface
- B01J2219/00637—Introduction of reactive groups to the surface by coating it with another layer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00702—Processes involving means for analysing and characterising the products
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00709—Type of synthesis
- B01J2219/00711—Light-directed synthesis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00725—Peptides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00729—Peptide nucleic acids [PNA]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00731—Saccharides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/12—Libraries containing saccharides or polysaccharides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
- C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
Definitions
- the invention relates to an optically transparent carrier substrate for a MALDI measuring arrangement (MALDI-MS: “Matrix Assisted Laser Desorption / Ionization Mass Spectrometry”) at at least one irradiated excitation wavelength, characterized in that said carrier substrate sequentially carries out one or more optical and one or one or allows several mass spectrometric measurements, as well as the correspondingly carried out coupled optical and mass spectrometric detection methods and their use.
- MALDI-MS “Matrix Assisted Laser Desorption / Ionization Mass Spectrometry”
- the invention also relates to a carrier substrate for a MALDI measuring arrangement which is optically transparent at at least one irradiated excitation wavelength, characterized in that the material of said carrier substrate comprises a metal oxide or a mixture of metal oxides, and mass spectrometric and coupled detection methods carried out with this carrier substrate and their use.
- MALDI-MS Microwave Assisted Laser Desorption / Ionization Mass Spectrometry
- the MALDI principle is based on the fact that the analyte, such as a peptide or protein, is embedded in a matrix of typically organic molecules of low molecular weight (eg sinapic acid) or is in contact with such a matrix.
- the matrix material is selected so that it is highly absorbent at the excitation wavelength of a strong, stimulating laser pulse.
- the sample matrix is evaporated into the vacuum of the MS apparatus.
- the or embedded in the matrix associated analyte molecules are also converted into the gas phase and optionally also ionized by proton transfer from the sample matrix. In this way, even large molecules up to a molecular weight of several hundred thousand daltons can be converted into the gas phase.
- time-of-flight (TOF) mass spectrometer In a typical mass spectrometric arrangement, the analyte ions are then accelerated for mass separation in an electrical field of a time-of-flight mass spectrometer ("time-of-flight (TOF) mass spectrometer").
- TOF time-of-flight
- a particular advantage of the MALDI method is that in the linear Little or no fragments of TOF-MS are detected, but they can be detected in a reflectron-TOF-MS, which can be used to determine both the molecular mass and structural elements of the measured compounds, which is a disadvantage of the fact that MALDI-MS predominantly only suitable for mass determination of larger molecules (with a molecular weight> 500 Da), whereas the presence of the sample matrix can have a disruptive effect in the range of small molecular weights.
- the carrier or frame for the MALDI matrix traditionally consists of an electrically conductive material, i.e. H. a metallic plate or grid [see e.g. B. U.S. Patent No. 5,580,434].
- a mass spectrometric apparatus based on the MALDI principle is referred to below as a "MALDI measuring arrangement".
- MALDI like other mass spectrometric analysis methods, enables substances to be identified based on their molecular weight.
- microarrays such as, for example, nucleic acid or protein microarrays
- detection platforms are available all known as “biochips”.
- biochips For this purpose, a large number of different biological or biochemical or synthetically producible recognition elements for the specific recognition and binding of the respective target analyte are immobilized in a two-dimensional arrangement on an essentially planar carrier.
- the sample is then brought into contact with the analytes to be detected and, if appropriate, further reagents with the detection elements immobilized on the carrier surface in an assay comprising a single or several addition steps.
- the qualitative and in many cases also quantitative detection of bound analyte molecules, from which their concentration in the sample under investigation is to be determined, can be carried out using a large number of different detection methods.
- Fluorescence-based detection methods are widely used. Since the analyte molecules to be detected are only fluorescent in the rarest of cases, so-called fluorescence labels are generally used for fluorescence-based analyte detection, which are bound, for example, to the analyte or to one of its binding partners.
- Arrays with a very high density of discrete measurement areas (“features”) are known based on simple glass or microscope plates. For example, US Pat. No. 5,445,934 describes and claims arrays of oligonucleotides with a density of more than 1000 features per square centimeter.
- excitation and reading out of such arrays is based on classic optical arrangements and methods, and the entire array can be illuminated simultaneously with an expanded excitation light bundle, but this leads to a relatively low sensitivity since the excitation light intensities related to the area are relatively low under these conditions
- confocal microscope measuring arrangements are often used and the various features sequ read out essentially by "scanning".
- an analyte detection in the evanescent field of an optical waveguide in particular a thin-film waveguide: If a light wave is coupled into a planar thin-film waveguide , which is surrounded by optically thinner media, it is guided by total reflection at the interfaces of the waveguiding layer.
- a planar thin-film waveguide consists of a three-layer system: carrier material, waveguiding layer, superstrate (or sample to be examined), the waveguiding layer having the highest refractive index. Additional intermediate layers can improve the effect of the planar waveguide.
- the strength of the evanescent field depends very much on the thickness of the waveguiding layer itself, as well as on the ratio of the refractive indices of the waveguiding layer and the media surrounding it. With thin waveguides, ie layer thicknesses of the same or lower thickness than the wavelength to be guided, discrete modes of the guided light can be distinguished.
- Different methods for the detection of analytes in the evanescent field of guided light waves in optical layer waveguides can be differentiated.
- a distinction can be made, for example, between fluorescence or general luminescence methods on the one hand and refractive methods on the other.
- methods for generating a surface plasmon resonance in a thin metal layer on a dielectric layer with a lower refractive index can be included in the group of refractive methods, provided that the resonance angle of the irradiated excitation light for generating the surface plasmon resonance serves as the basis for determining the measurement variable.
- Surface plasmon resonance can also be used to enhance luminescence or to improve the signal-to-background ratio in a luminescence measurement.
- the conditions for generating a surface plasmon resonance, as well as for combination with luminescence measurements, as well as with wave-guiding structures, are often described in the literature.
- luminescence is used in this application to describe the spontaneous emission of photons in the ultraviolet to infrared range according to optical or non-optical, such as electrical or chemical or biochemical or thermal excitation.
- chemiluminescence, bioluminescence, electroluminescence and in particular fluorescence and phosphorescence are included under the term “luminescence”. Fluorescence and phosphorescence are particularly preferred forms of luminescence.
- the change in the so-called effective refractive index due to molecular adsorption or desorption on the waveguide is used to detect the analyte.
- This change in the effective refractive index in the case of grating coupler sensors, is determined from the change in the coupling angle for the coupling in or out of light into or out of the grating coupler sensor, and in the case of interferometric sensors from the change in the phase difference between the a sensor arm and a reference arm of the interferometer-guided measurement light.
- the refractive methods mentioned have the advantage that they can be used without the use of additional labeling molecules, so-called molecular labels.
- the disadvantage of these label-free methods is, however, that the detection limits that can be achieved with them are limited to picosolar to nanomolar concentration ranges due to the low selectivity of the measurement principle, depending on the molecular weight of the analyte, which is not sufficient for many applications, for example for diagnostic applications.
- luminescence-based methods appear more suitable due to the greater selectivity of the signal generation.
- the luminescence excitation is limited to the depth of penetration of the evanescent field into the optically thinner medium, i.e. to the immediate vicinity of the wave-guiding region with a depth of penetration of the order of a few hundred nanometers into the medium. This principle is called evanescent luminescence excitation. This method of excitation is of great importance for analysis, since it can be used to minimize disruptive influences from the depth of the medium.
- optical detection methods mentioned have been expanded in recent years from sensor platforms for determining individual analytes on platforms with hundreds to thousands of different detection elements immobilized in discrete measurement areas (“spots”) for determining a large number of different analytes on a common platform (“microarrays”).
- spots discrete measurement areas
- microarrays common platform
- kinetics of the interactions between analytes and their immobilized recognition elements can be monitored in real time using surface-based detection methods, for example based on interactions in the evanescent field of a waveguide or a surface plasmon.
- optical detection methods mentioned do not enable identification of the bound analyte molecules, which is necessary, for example, for screening applications.
- a second, more elegant approach is based on the direct use of the SPR chip after completion of the optical (SPR) measurement as a carrier (“probe”) in the MALDI device.
- the MALDI matrix was placed on the SPR Chip applied [RW Nelson, JW Jarvik, BE Taillon and KA Tubbs, "BIA / MS of epitope-tagged peptides directly from E. CoZ lysate: multiplex detection and proetin identification at low-femtomole to subfemtomole levels", Analytical Chemistry 71 (1999 ) 2858-2865].
- the carrier material (SPR chip surface) was gold, ie an optically non-transparent material (in the sense of the definition below).
- Optical transparency of the material or of a carrier substrate should be understood to mean that the run length of a light guided in said material or in said carrier substrate or in the (highly refractive) waveguiding film of a carrier substrate designed as an optical waveguide is at least a portion of the visible spectrum (between 400 nm and 750 nm) is larger than 2 mm, unless this run length is limited by structures for changing the direction of propagation of said light.
- the run length of optically visible light ie the distance on the path of the Light in the corresponding material, until the light intensity decreases to a value 1 / e of the original intensity when light enters this material, in the order of a few centimeters (e.g.
- the propagation length of a light guided in the waveguiding layer can be limited to a few micrometers by a coupling-out diffractive grating (formed in the waveguiding layer).
- this limitation of the barrel length is due to the structuring and not the material properties of the structure.
- such a grating waveguide structure should be referred to as “optically transparent”.
- the propagation length of a thin metal film is due to the high absorption of the metal in question, that is to say due to the material, over distances limited in the order of magnitude of at most 100 ⁇ m to 200 ⁇ m. Accordingly, such an SPR structure, based on a thin metal film for producing a surface plasmon resonance, should be referred to as “optically non-transparent”.
- US Pat. Nos. 5,770,860 and 6,287,872 describe sample carriers with the basic dimensions of a microtiter plate to enable high-throughput measurements for screening applications. However, no information is given about the carrier material and its optical properties.
- US Pat. No. 6,043,031 describes "chips" as sample carriers for the mass spectrometric determination of nucleic acid sequences. Glass chip filters, glass and metal surfaces (steel, gold, silver, aluminum, copper and silicon) are used as “chip” materials ) and plastic (polyethylene, polypropylene, polyamide, polyvinylidene fluoride membranes or microtiter plates). Again, however, there is no indication of a combination of the mass spectrometric detection method with optical detection methods.
- an optically transparent carrier substrate the surface of which comprises a metal oxide, preferably TiO 2 or Ta 2 O 5 or Nb O 5 , is very suitable for a MALDI measuring arrangement.
- the first object of the invention is an optically transparent carrier substrate for a MALDI measuring arrangement at at least one irradiated excitation wavelength, characterized in that said carrier substrate allows sequential execution of one or more optical and one or more mass spectrometric measurements.
- the carrier substrate can comprise a material from the group of glass, quartz, optically transparent ceramics, metal oxides, optically transparent plastics, in particular transparent thermoplastic plastics, such as, for example, polycarbonates, acrylates, polyacrylates, in particular polymethyl methacrylates and polystyrenes. It is preferred that said optically transparent plastics are moldable, embossable, sprayable and / or millable.
- the invention also relates to a carrier substrate for a MALDI measuring arrangement which is optically transparent at at least one irradiated excitation wavelength, characterized in that the surface of said carrier substrate comprises a metal oxide or a mixture of metal oxides.
- the material of an optically transparent carrier substrate according to the invention for a MALDI measuring arrangement comprises a metal oxide from the group formed by TiO 2 , ZnO, Nb 2 O 5 , Ta 2 O 5 , HfO, and ZrO 2 , wherein TiO 2 , Ta 2 O 5 and Nb 2 O 5 are particularly preferred.
- a MALDI matrix consisting of molecules strongly absorbing at the wavelength of a laser pulse irradiated in the desorption step, is applied to the surface of a carrier substrate according to the invention, directly as the first layer or to further layers applied to the carrier substrate surface.
- Said MALDI matrix preferably comprises compounds from the group of hydroxybenzoic acids, such as, for example, gallic acid, gentisic acid (2,5-hydroxybenzoic acid) and 2- (4-hydroxyphenylazo) benzoic acid, succinic acid, 3-hydroxy-picolinic acid, caffeic acid, ferulic acid, 4-nitroaniline , Anthranilic acid, salicylamide, isovanillin, dithranol, 3-aminoquinoline, 1-hydroxyisoquinoline, nicotinic acid, sinapic acid, trans-3-indolacrylic acid, cinnamic acid and their derivatives, such as trans-3,5-dimethoxy-4-hydroxy-cinnamic acid as well as ⁇ -cyano-4-hydroxy-cinnamic acid, di- and trihydroxy-acetophenones (e.g., hydroxybenzoic acids, such as, for example, gallic acid, gentisic acid (2,5-hydroxybenzoic acid)
- the MALDI matrix is designed as a self-assembled monolayer (“self-assembled monolayer”, SAM).
- the analyte molecules to be determined by mass spectrometry can be embedded in the MALDI matrix. It is also possible for the MALDI matrix to be applied to the carrier substrate after the analyte molecules have been applied.
- a likewise transparent adhesive layer is applied to said carrier substrate for immobilizing the analyte molecules, which preferably has a thickness of less than 200 nm, particularly preferably less than 20 nm.
- an adhesion promoter layer compounds from the group of silanes, functionalized silanes, epoxides, functionalized, charged or polar polymers and "self-organized passive or functionalized mono- or multilayers", alkyl phosphates and phosphonates and multifunctional block copolymers, such as, for example Poly (L) lysine / polyethylene glycols.
- adhesion promoter layer comprises compounds from the group of organophosphoric acids of the general formula I (A)
- B is an alkyl, alkenyl, alkynyl, aryl, aralkyl, hetaryl or hetarylalkyl radical and Y is hydrogen or a functional group from the series hydroxyl, carboxy, amino, optionally mono- or substituted by lower alkyl Dialkylamino, thiol, or a negative acid group from the series consisting of ester, phosphate, phosphonate, sulfate, sulfonate, maleimide, succinimydyl, epoxy or acrylate, with B or Y being a biological, biochemical or synthetic producible recognition element can be docked by addition or substitution reaction, it also being possible to attach compounds which give the substrate surface resistance to protein adsorption and / or cell adhesion and in B in the chain optionally one or more ethylene oxide groups instead of one or more CH 2 groups can be included.
- An important group of important embodiments of an optically transparent carrier substrate according to the invention is characterized in that biological or biochemical or synthetically producible recognition elements are immobilized on the surface of the carrier substrate or on the adhesion-promoting layer applied to the carrier substrate, for the recognition and binding of one or more analytes from one or more several samples which are brought into contact with said recognition elements.
- analyte molecules prefferably be determined by mass spectrometry to be applied to the MALDI matrix located on the carrier substrate.
- Biological or biochemical or synthetically producible recognition elements can also be immobilized on the MALDI matrix applied to the carrier substrate, for the recognition and binding of one or more analytes from one or more samples which are brought into contact with said recognition elements.
- the MALDI matrix also has the function of an adhesion promoting layer or if an adhesion promoting layer applied to said carrier substrate has the function of a MALDI matrix.
- a layer applied to the carrier substrate can also be present as a mixture of a MALDI matrix and an adhesion-promoting layer.
- a mixture of the molecules to be formed and the one MALDI matrix is first Adhesion promoting layer to be formed molecules in liquid solution. This mixture solution is then applied to the carrier substrate, on which the mixed layer remains after the solvent has evaporated.
- an optically transparent carrier substrate is therefore characterized in that the analyte molecules to be determined by mass spectrometry or the chemical or biological or synthetically producible detection elements are immobilized in discrete measurement areas (spots) on said carrier substrate or on an adhesion-promoting layer applied thereon or on the MALDI matrix are.
- up to 1 000 000 measuring ranges can be arranged in a 2-dimensional arrangement.
- a single measuring range can, for example, occupy an area of 0.001 - 6 mm 2 . It is preferred that in a 2-dimensional arrangement more than 100, preferably more than 1000, particularly preferably more than 10,000 measuring ranges are arranged per square centimeter.
- the measuring ranges can therefore each comprise a multiplicity (i.e. two or more) of different types of analyte molecules to be determined by mass spectrometry or of (bio) chemical or biological or synthetically producible detection elements.
- a special embodiment of an optically transparent carrier substrate according to the invention is characterized in that the surface thereof comprises pure or mixed oxides, nitrides or carbides of metals or semiconductors and then chemical structuring by local deposition of mono- or multilayers from organophosphates and / or organophosphonates (according to the preceding Description) is generated. It is preferred that the surface of said carrier substrate has a defined pattern with silicon oxide or transition metal oxides. For this embodiment, it is also advantageous if further mono- or multilayers composed of organophosphates and / or organophosphonates are applied to the silicon oxide regions by deposition from organic solvents.
- an optically transparent carrier substrate according to the invention is characterized in that its surface comprises pure or mixed oxides, nitrides or carbides of metals or semiconductors and generates local hydrophobic or hydrophilic areas thereon by local deposition of mono- or multilayers from organophosphates and / or organophosphonates are and the surrounding substrate surface is covered with a terminally hydrophobic or hydrophilic monolayer.
- said MALDI matrix or said adhesive layer or said monolayers or multilayers and / or said biological or biochemical or synthetically producible recognition elements are applied by means of a method which is selected from the group consisting of dipping, spraying, spreading, brushing, "inkjet spotting", mechanical spotting using a pen, Spring or capillary, "micro contact printing", fluidic contacting of the substrate surface with parallel or crossed microchannels, under the influence of pressure differences or electrical or electromagnetic potentials ", photolithographic immobilization methods etc. includes.
- the biological or biochemical or synthetically producible recognition elements can be selected from the group consisting of nucleic acids (for example DNA, RNA, oligonucleotides) and nucleic acid analogs (for example PNA) and their derivatives with artificial bases, mono- or polyclonal antibodies, antibody fragments, Peptides, enzymes, aptamers, synthetic peptide structures, glycopeptides, glycoproteins, oligosaccharides, lectins, soluble, membrane-bound proteins isolated from a membrane, such as receptors, their ligands, antigens for antibodies (e.g. biotin for streptavidin), "histidine Tag components "and their complex formation partners, cavities generated by chemical synthesis for receiving molecular imprints, etc. is formed.
- nucleic acids for example DNA, RNA, oligonucleotides
- nucleic acid analogs for example PNA
- the analyte molecules to be determined by mass spectrometry can be selected from the group consisting of nucleic acids (for example DNA, RNA, oligonucleotides) and nucleic acid analogs (for example PNA) and their derivatives with artificial bases, mono- or polyclonal antibodies, peptides, enzymes, Aptamers, synthetic peptide structures, glycopeptides, glycoproteins, oligosaccharides, lectins, soluble, membrane-bound proteins isolated from a membrane, such as receptors, their ligands, antigens for antibodies (e.g. biotin for streptavidin), "histidine tag components" and their complex formation partners are formed.
- nucleic acids for example DNA, RNA, oligonucleotides
- nucleic acid analogs for example PNA
- both biological or biochemical or synthetically producible recognition elements and analyte molecules to be determined by mass spectrometry can each be selected from the group consisting of acetylenes, alkaloids (for example alkaloids with pyridines, pyperidines, tropanes, quinolines, isoquinolines, tropilidenes, imidazoles, indoles, purines, Ring structures containing fenantridines), alkaloid glycosides, amines, benzofurans, benzophenones, naphthoquinones, betaines, carbohydrates (e.g.
- the recognition elements mentioned can be immobilized in isolated form or in an artificial or natural complex environment, for example as a component of cells, cell fragments, tissue (“tissue slices”) membranes etc.
- areas between the spatially separated measuring areas are "passivated” to minimize non-specific binding of analytes or their detection substances, ie that between the spatially separated measuring areas (d) are "chemically” compared to the analyte neutral "connections are applied, preferably consisting for example of the Groups derived from albumins, in particular bovine serum albumin or human serum albumin, casein, non-specific, polyclonal or monoclonal, foreign or empirically unspecific antibodies (in particular for immunoassays) for the analyte (s) to be detected, detergents - such as from the Tween series, in particular Tween 20 - , not to be analyzed with polynucleotides that hybridize, fragmented natural or synthetic DNA, such as an extract of herring or salmon sperm (especially for polynucleotide hybridization assays), or also uncharged, but hydrophilic polymers, such as
- a preferred embodiment of an optically transparent carrier substrate according to the invention is characterized in that it comprises an optical waveguide which is essentially planar.
- Such an embodiment of an optically transparent carrier substrate is particularly preferred, which comprises an optical thin-film waveguide with a layer (a) which is transparent at at least one excitation wavelength on a layer (b) which is also transparent at at least this excitation wavelength and has a lower refractive index than layer (a).
- the optically transparent layer (b) can comprise a material from the group consisting of silicates, e.g. B. glass or quartz, transparent thermoplastic or sprayable plastic, for example polycarbonates, polyimides, acrylates, in particular polymethyl methacrylates, or polystyrenes is formed.
- the refractive index of the optically transparent layer (a) is preferably greater than 1.8.
- the optically transparent layer (a)) be a material from the group of TiO, ZnO, Nb 2 O 5) Ta 2 ⁇ 5 , Hf0 2 , or ZrO 2 , but particularly preferably made of TiO or Ta 2 O 5 or Nb 2 O 5 .
- the thickness of layer (a) is 40 nm - 1000 nm, preferably 100 nm - 300 nm.
- Various methods for coupling an excitation light into a planar optical waveguide are known.
- end face coupling using lenses placed in front of an end face of the waveguide, in particular cylindrical lenses is a widely used method.
- a cylindrical lens which serves to couple light in can also itself be part of an end face of an optical waveguide.
- Such a structure can be produced, for example, by injection molding a transparent plastic (such as polystyrene).
- an optical waveguide and a coupling prism placed thereon can also be produced as a single component in a single production step by injection molding. It is more widespread that a prism, typically made of glass or a transparent plastic, is placed on a planar waveguide. In order to reduce reflections at the boundary layers and in particular the disturbance of air gaps between the waveguide and the prism, a liquid that adjusts the refractive index between the prism and the waveguide is often used. It is advantageous if the difference in the refractive indices of the liquid and the waveguiding layer is as small as possible.
- the coupling of light using diffractive coupling gratings connected to the waveguiding layer is particularly advantageous.
- An optically transparent carrier substrate which comprises an essentially planar optical waveguide and is characterized in that said carrier substrate comprises one or more optical coupling elements from the group of face-coupled cylindrical lenses or optical fibers as light guides, coupling prisms and optical coupling gratings preferred if said carrier substrate comprises one or more lattice structures (c) as coupling lattice, which as Surface relief grids are modulated in the optically transparent layer (a).
- said carrier substrate comprises one or more optical coupling elements from the group of face-coupled cylindrical lenses or optical fibers as light guides, coupling prisms and optical coupling gratings preferred if said carrier substrate comprises one or more lattice structures (c) as coupling lattice, which as Surface relief grids are modulated in the optically transparent layer (a).
- Such lattice structures (c) are advantageously mono- or multi-diffractive and have a depth of 2 nm - 100 nm, preferably of 10 nm - 30 nm, and a period of 200 nm - 1000 nm, preferably of 300 nm - 700 nm.
- Another object of the invention is a coupled detection method for the qualitative and / or quantitative determination and mass spectrometric identification of one or more analytes, characterized in that an optically transparent carrier substrate according to the invention, according to one of the above-mentioned embodiments, with one or more samples with the detection therein Analyte is brought into contact and optical and mass spectrometric detection are carried out sequentially.
- the characteristic of such an optical detection method according to the invention is that, as part of the optical method step for the simultaneous or sequential, qualitative and / or quantitative detection of one or more analytes in one or more samples, said samples and optionally further reagents with those on a carrier substrate (directly or mediated via one or more layers) of immobilized recognition elements for specific recognition and binding of said analytes are brought into contact and changes in optical or electronic signals resulting from the binding of these analytes or other detection substances used for analyte detection are measured.
- the one or more samples are preincubated with a mixture of the various detection reagents to determine the analytes to be detected in said samples and these mixtures are then each in a single addition step with the immobilized recognition elements be brought into contact.
- a preferred embodiment of a coupled detection method according to the invention is characterized in that the optical detection of one or several analytes is based on the determination of the change in the effective refractive index on the surface of the carrier substrate carrying the immobilized biological or biochemical or synthetically producible recognition elements, on the basis of molecular adsorption or deodorization.
- a special embodiment of the coupled detection method is characterized in that the optical detection of the one or more analytes is based on the determination of the change in the phase difference between a light component of an incident detection light that interacts with the areas of the immobilized detection elements and a reference component.
- Such a special embodiment can be carried out in such a way that the incident detection light is polychromatic and the optical detection of the one or more analytes is based on the determination of the change in the spectral distribution of interference maxima and minima, under a predetermined observation angle.
- the method can also be carried out in such a way that the optical detection of the one or more analytes is based on the determination of the change in the spatial distribution of interference maxima and minima.
- the incident detection light is monochromatic.
- optical detection of the one or more analytes is based on the determination of the change in one or more luminescences.
- the excitation light from one or more light sources is irradiated in an incident light excitation arrangement.
- the excitation light from one or more light sources is irradiated in a transmission light excitation arrangement.
- a particularly preferred embodiment of a coupled detection method according to the invention is characterized in that the biological or biochemical recognition elements, for the specific recognition and binding of one or more analytes, are immobilized on a preferably planar optical waveguide as a carrier substrate (directly or via one or more layers), immobilized that the one or more samples with the one or more analytes to be detected therein and possibly further detection reagents are brought into contact with said immobilized detection elements sequentially or after mixing with said samples in a single step and that the excitation light from one or more light sources is coupled into the optical waveguide with the help of one or more optical coupling elements from the group consisting of cylindrical lenses coupled to the end faces, optical fibers as Lic htleitern, coupling prisms and optical coupling grids is formed.
- a possible variant was characterized in that the optical detection of the one or more analytes in the near field (evanescent field) of an optical layer waveguide as a carrier substrate, with a layer (a) transparent at least at one excitation wavelength on a layer which is also transparent at at least this excitation wavelength ( b) with a lower refractive index than layer (a), and over a grating structure (c) or (c ') which is pronounced in layer (a) of the optical layer waveguide, based on the biological immobilized on the analyte and / or other detection reagents or biochemical or synthetically producible detection elements, resulting changes in the resonance conditions for coupling an excitation light into the layer (a) of a carrier designed as a layer waveguide or for coupling out light carried in the layer (a).
- Characteristic of a sub-variant is that the optical detection of the one or more analytes on the change in the coupling angle of an incident on a grating structure (c) embossed in the layer (a), essentially monochromatic detection light in layer (a), due to the binding of the analyte and / or further detection reagents, to whose biological or biochemical or synthetically producible detection elements immobilized in the area of this lattice structure.
- “Essentially monochromatic” is understood to mean that the spectral bandwidth of an excitation light radiated onto the grating structure (c) is at most 20 nm, preferably at most 5 nm, particularly preferably at most 1 nm.
- Essentially parallel is understood here to mean that the angle of convergence or divergence (opening angle) of an excitation light radiated onto the grating structure (c) is at most 5 °, preferably at most 1 °, particularly preferably at most 0.2 °.
- the invention also relates to a coupled detection method, which is characterized in that the optical detection of the one or more analytes on a spatially resolved determination of changes in the resonance conditions for coupling an excitation light into the layer (a) or coupling out one in the layer ( a) based on a layer waveguide as the carrier substrate, with a two-dimensional array of at least four or more spatially separated measurement areas on this layer waveguide as the carrier substrate, with a first optically transparent layer (a) on a second optically transparent layer (b) with a lower refractive index than layer (a),
- the density of the measurement areas on a common grid structure (c) being at least 10 measurement areas per square centimeter and said excitation light being simultaneously irradiated onto said array of measurement areas and the degree of fulfillment of the resonance condition for the light coupling into the layer (a) is measured simultaneously to said measuring ranges and crosstalk of excitation light carried in layer (a) from one measuring range to one or more adjacent measuring ranges by means of the coupling out of this excitation light in the middle ls the lattice structure (c) is prevented.
- Another preferred object of the invention is a coupled detection method, wherein an optical waveguide is formed as a layer waveguide as a carrier substrate with a first optically transparent layer (a) on a second optically transparent layer (b) with a lower refractive index than layer (a), furthermore Excitation light with the aid of one or more grating structures (c) or (c '), which are pronounced in the optically transparent layer (a), is coupled into the optically transparent layer (a) and is guided as a guided wave to the measuring areas (d) located thereon, and wherein the luminescence of molecules capable of luminescence generated in the evanescent field of said guided wave is detected with one or more detectors and the relative amount or concentration of one or more analytes is determined from the intensity of these luminescence signals.
- Such an embodiment of the coupled detection method according to the invention is particularly suitable for highly sensitive optical detection of one or more analytes in one or more samples, in that said samples with the analytes to be detected therein and optionally further detection reagents are added sequentially or after mixing with said samples in a single step on a planar optical waveguide as a carrier substrate (directly or via one or more layers) immobilized biological or biochemical or synthetically producible recognition elements, for specific recognition and binding of said analytes, and that the excitation light from one or more light sources in the optical Waveguide (ie the waveguiding layer (a)) is coupled in using one or more optical coupling elements (preferably using a grating structure (c) formed in layer (a)).
- (1) the isotropically emitted luminescence or (2) luminescence coupled into the optically transparent layer (a) and coupled out via a lattice structure (c) or (c ') or luminescence of both portions (1) and (2) can be measured simultaneously.
- the analyte molecules or the chemical or biological or synthetically producible recognition elements in discrete measurement areas (spots) on said carrier substrate or on an adhesion-promoting layer applied thereon or on the MALDI - Matrix are immobilized and that the light emanating from the discrete measuring areas is measured and recorded with one or more detectors in an imaging process.
- Different or identical analytes or recognition elements can be used in different discrete measurement ranges Detection of different or the same analytes can be applied.
- Several different analytes or detection elements for detecting different analytes can also be applied in a single measuring range.
- an applied biological or biochemical or synthetically producible detection element typically serves for the specific detection of an individual analyte.
- an immobilized recognition element can also be designed in such a way that it serves for the detection of several, ie of two or more, different analytes as a result of their binding to different discrete recognition regions of the recognition element.
- discrete sections with different base sequences can serve to bind different (single-stranded) nucleic acids to be detected in a sample with sequences complementary to the discrete sections.
- the data recorded in an (imaging) coupled detection method according to the invention are typically stored in a two-dimensional data matrix on a data carrier.
- a luminescent dye or luminescent nanoparticle is used as the luminescent label, which is used at a wavelength between 300 nm and 1100 nm can be excited and emitted.
- the luminescence label can be bound to the analyte or in a competitive assay to an analog of the analyte or in a multi-stage assay to one of the binding partners of the immobilized biological or biochemical or synthetically producible recognition elements or to the biological or biochemical or synthetically producible recognition elements.
- a special embodiment of the method is characterized in that a second or even further luminescence label with the same or different one Excitation wavelength as the first luminescence label and the same or different emission wavelength can be used.
- the second or even more luminescent label can be excited at the same wavelength as the first luminescent dye, but emit at other wavelengths.
- a variant of the method consists in that charge or optical energy transfer from a first luminescence label serving as donor to a second luminescence label serving as acceptor is used to detect the analyte.
- a further embodiment of the method is characterized in that, in addition to the determination of one or more luminescences, changes in the effective refractive index on the measurement areas are determined.
- a further development of the method is characterized in that the one or more luminescences and / or determinations of light signals are carried out polarization-selectively at the excitation wavelength.
- the one or more luminescences are measured with a different polarization than that of the excitation light.
- a coupled detection method according to the invention according to one of the embodiments mentioned can be used for simultaneous or sequential, quantitative or qualitative determination of one or more analytes from the group of proteins, such as, for example, antibodies or antibody fragments, antigens, receptors and their ligands, chelators, with additional binding sites of functionalized proteins (“tag proteins”, such as “histidine tag proteins”) ) and their complex formation partners, natural or modified nucleic acids, such as oligonucleotides, DNA or RNA strands, DNA or RNA analogs, enzymes, enzyme cofactors or inhibitors, lectins and primary or secondary metabolites of biological processes.
- proteins such as, for example, antibodies or antibody fragments, antigens, receptors and their ligands, chelators, with additional binding sites of functionalized proteins (“tag proteins”, such as “histidine tag proteins”)
- tag proteins such as “histidine tag proteins”
- nucleic acids such as oligonucleotides, DNA or RNA strands, DNA or
- the method can also be used to determine substances from the group of acetylenes, alkaloids (for example alkaloids with pyridines, pyperidines, tropanes, quinolines, isoquinolines, tropilidenes, imidazoles, indoles, purines, fenantridines-containing ring structures), alkaloid glycosides, amines, benzofurans, Benzophenones, naphthoquinones, betaines, carbohydrates (e.g.
- the samples to be examined can be aqueous solutions, in particular buffer solutions or naturally occurring body fluids such as blood, serum, plasma, lymph or urine or tissue fluids or, for example, egg yolk his.
- a sample to be examined can also be an optically cloudy liquid, surface water, a soil or plant extract or a bio or synthesis process broth.
- the samples can also be prepared from biological tissue parts or cell cultures.
- Another object of the invention is a method for the mass spectrometric determination of one or more analytes, characterized in that a carrier substrate according to the invention according to one of the above-mentioned embodiments is used in a MALDI measuring arrangement, the carrier substrate having a metal oxide surface, preferably from the group comprising TiO 2 , ZnO , Nb 2 O 5 , Ta 2 O 5 , HfO 2 , and ZrO 2 .
- the mass spectrometric determination method according to the invention is preferably carried out in such a way that the signals from ions with a low mass-to-charge quotient, in particular from the MALDI matrix, are minimized by means of time-delayed application of the acceleration voltage in the time-of-flight tube of the MALDI measuring arrangement after the laser-induced deodorization step can.
- the metal oxide of the carrier substrate surface is selected from the group comprising TiO 2 , ZnO, Nb 2 O 5 , Ta 2 O 5 , HfO 2 , and ZrO 2 .
- a coupled detection method is also part of the present invention, which is characterized in that a carrier substrate according to one of the above-mentioned embodiments is used for the part of the mass spectrometric detection of one or more analytes in a MALDI measuring arrangement.
- a carrier substrate according to one of the above-mentioned embodiments is used for the part of the mass spectrometric detection of one or more analytes in a MALDI measuring arrangement.
- analyte molecules immobilized on a MALDI matrix applied to the carrier substrate or analyte molecules bound to biological or biochemical or synthetically producible recognition elements within the scope of the optical detection are analyzed by mass spectrometry after completion of the optical detection step in a MALDI measuring arrangement.
- a preferred embodiment is characterized in that after the completion of the optical detection step on the carrier substrate with directly on said carrier substrate or on an adhesion-promoting layer immobilized on the carrier substrate or with analyte molecules immobilized on directly on said carrier substrate or on a biochemically bonded adhesion-promoting layer or on the carrier substrate or synthetically producible recognition elements, a MALDI matrix is applied to the bound analyte molecules and the immobilized or bound analyte molecules are analyzed by mass spectrometry in a MALDI measuring arrangement.
- the method is preferably carried out in such a way that the signals from ions with a low mass-to-charge quotient, in particular from the MALDI matrix, can be minimized by applying the acceleration voltage in the time-of-flight tube of the MALDI measuring arrangement after the laser-induced deodorization step.
- the metal oxide of the carrier substrate surface is selected from the group comprising TiO 2 , ZnO, Nb 2 O 5 , Ta 2 O 5 , HfO 2 , and ZrO 2 .
- analyte molecules or the chemical or biological or synthetically producible recognition elements with analyte molecules possibly attached to them, to be immobilized in discrete measurement areas (spots) on said carrier substrate or on an adhesion-promoting layer or on the MALDI matrix, and that discrete measuring areas can be analyzed sequentially in a MALDI measuring arrangement using mass spectrometry.
- measuring areas to comprise a large number of different types of analyte molecules to be determined by mass spectrometry or of (bio) chemical or biological or synthetically producible detection elements, which with spatial resolution within said Measuring ranges in a MALDI measuring arrangement are analyzed by mass spectrometry.
- up to 1 000 000 measuring ranges are arranged in a 2-dimensional arrangement and that a single measuring range occupies an area of 0.001 - 6 mm 2 , and that said measuring ranges are analyzed sequentially in a MALDI measuring arrangement by mass spectrometry.
- more than 100, preferably more than 1000, particularly preferably more than 10,000 measurement areas per square centimeter are arranged in a 2-dimensional arrangement, and that said measurement areas are analyzed sequentially in a MALDI measurement arrangement by mass spectrometry.
- the method according to the invention is suitable for the mass spectrometric determination of one or more analytes from the group of proteins, such as, for example, antibodies or antibody fragments, antigens, receptors and their ligands, chelators, with additional binding sites of functionalized proteins (“tag proteins”, such as, for example, “histidine proteins, Tag proteins ”) and their complex formation partners, natural or modified nucleic acids, such as oligonucleotides, DNA or RNA strands, DNA or RNA analogs, enzymes, enzyme cofactors or inhibitors, lectins. Carbohydrates and primary or secondary metabolites of biological processes.
- the method can also be used for the mass spectrometric determination of one or more analytes from the group consisting of ring structures containing acetylenes, alkaloids (for example alkaloids with pyridines, pyperidines, tropanes, quinolines, isoquinolines, tropilidenes, imidazoles, indoles, purines, fenantridines) , Amines, benzofurans, benzophenones, naphthoquinones, betaines, carbohydrates (e.g.
- sugar, starch and cellulose derivatives carbolines, cardenolides, catechols, chalcones, coumarins, cyclic peptides and polypeptides, depsipeptides, diketopethernavins, diphenene , Isoflavanones, flavonoid Alkaloids, furanoquinoline alkaloids, gallocatechins, glycosides, antrachinones, flavonoids, lactones, phenols, hydroquinones, indoles, indoloquinones, alginic acids, lipids (for example oils, waxes and other fatty acid derivatives), macrolides, oligopeptides, oloxidenidenphenphenglyphenol, peroxylphenyl, phenol glycosides, Polyethers, "polyether antibiotics", pterocaphins, pyranocoumarins, pyrroles, quassins, quinolines, saframycines,
- Another object of the invention is the use of an optically transparent carrier substrate and / or a method according to one of the above-mentioned embodiments for quantitative or qualitative analyzes for determining or enriching or identifying chemical, biochemical or biological analytes in screening processes in pharmaceutical research (in particular high-throughput screening, "High Trough-Put Screening HTS"), clinical and preclinical development, real-time binding studies and the determination of kinetic parameters in affinity screening and research, qualitative and quantitative analyte determinations, in particular for DNA and RNA analysis, for the preparation of Toxicity studies and for the determination of gene or protein expression profiles as well as for the detection of antibodies, antigens, pathogens or bacteria in pharmaceutical product development and research, human and veterinary diagnostics, agrochemis Chen product development and research, symptomatic and presymptomatic plant diagnostics, for patient stratification in pharmaceutical product development and for therapeutic drug selection, for the detection of pathogens, pollutants and pathogens, especially of Salmonella, prions, viruses and bacteria, in food and environmental analysis.
- Optically transparent carrier substrate with a metal oxide surface, for a MALDI measuring arrangement and detection method carried out with it
- a solution of the peptide melittin (molecular weight 2846.5 Da) is mixed with sinapic acid (MALDI matrix).
- a drop of the mixture (approx. 1 ⁇ l) is applied to the unstructured part of the tantalum pentoxide surface of the carrier substrate according to the invention.
- a drop of the pure sinapic acid is applied to another point on the tantalum pentoxide surface. After the drops have dried to “spots”, each about 1 mm in diameter, mass spectra are recorded from the areas of the two spots.
- experiment a) is repeated on a glass surface (AF 45, rear side of the optically transparent substrate described under a) and on a substrate with a gold surface, as is conventionally used as a MALDI substrate carrier.
- the result is mass spectra of comparable but not better quality than that described under a) (FIG. 3). In the case of these surfaces, however, the signals of the sample matrix cannot be completely vanished by applying the acceleration voltage with a time delay.
- Example 2 A similar carrier substrate as described at the beginning of Example 1 is used. Ten discrete measuring areas (spots) are applied to the tantalum pentoxide surface by applying 1 ⁇ l of an antibody solution (120 ⁇ g / ml anti-interleukin 4 antibodies in 1:10 diluted phosphate salt buffer ("1/10 PBS").
- 2 reference spots without biochemical recognition elements for an analyte, are applied by applying 1 ⁇ l BSA solution in buffer (for passivation non-specific, free binding sites on the surface with bovine serum albumin (BSA), 1/10 PBS with 3% BSA, which is not binding for the analyte), the carrier substrate is incubated for one hour at room temperature with the applied droplets in a humidity chamber, then with 1/10 PBS buffer rinsed and then incubated again with passivation buffer for one hour.
- BSA bovine serum albumin
- sample solution with human interleukin 4 (h-IL 4, 1 ⁇ g / ml) in assay buffer (PBS / 10) are in contact with the entire surface of the carrier substrate brought and incubated for one hour. Then the surface of the carrier substrate is rinsed three times with 1 mL assay buffer and then extensively with water.
- h-IL 4 human interleukin 4
- MALDI matrix sinapic acid (3,5-dimethoxy-4-hydroxycinnamic acid) in 50% AcCN / 0.1% TFA (acetonitrile / tri-fluoro-acetic acid) is applied to the substrate support.
- Both the spots provided for the analyte detection and the spots provided as a reference are then analyzed by mass spectrometry using a MALDI measuring arrangement.
- the mass spectra from the area provided for the analyte detection show clear signals at an (m / z) value of 15 kDa (corresponding to the molecular weight of h -IL 4), which demonstrates the selective detection and binding of the analyte in the intended measuring areas (spots) on the carrier substrate (FIG. 6).
- the signals of the sample matrix can be completely suppressed by applying the acceleration voltage with a time delay, and the spectra quality can thus be significantly increased.
- improved resolution of the spectra ie a reduced peak width and an improved signal-to-noise ratio, were observed.
- the intensity of the incident laser pulses for laser-induced desorption can be reduced under these conditions.
- the conditions of the MALDI measuring arrangement can be set for a carrier substrate according to the invention in such a way that the analytes bound in a bioaffinity assay can be selectively released during the deodorization step and identified by mass spectrometry, while their recognition elements immobilized as specific binding partners remain on the carrier substrate.
- Example 2 Optically transparent carrier substrate for a MALDI measuring arrangement, which sequentially enables an optical and a mass spectrometric measurement to be carried out, and a coupled detection method performed therewith
- two surface relief gratings with a grid period of 318 nm (with orientation of the grating lines parallel to the width of the plate) and a grating depth of (12 +/- 3) nm are structured at a distance of 9 mm, which are involved in the coating process transferred the tantalum pentoxide film on a scale of 1: 1 to its surface.
- the length of these lattice structures (parallel to the length of the plate) is 0.5 mm in each case.
- the binding of human interleukin 4 (h-IL 4, R&D Systems, 7) can be quantified and identified as an analyte.
- the preparation of the carrier substrate, including the immobilization of the recognition elements, is carried out as described in example ld).
- the sample solution with h-IL 4 to be detected is preincubated (60 minutes) with a biotinylated, secondary anti-h-IL 4 antibody and Cy5-labeled streptavidin (to generate a fluorescence signal).
- the solution mixture thus produced is then applied in a single step to the carrier substrate with the immobilized primary anti-h-IL 4 antibodies.
- the carrier substrate is then inserted into an optical measuring arrangement for the excitation and detection of fluorescence in a planar optical waveguide.
- a suitable optical measuring arrangement is described, for example, in the application PCT / EP 01/10012, the content of which is considered to be a complete part of the present application.
- Possible embodiments and the individual steps of the optical detection method are described, for example, in the application PCT / EP 01/05995, the content of which is also regarded as a complete part of the present application.
- the excitation light of a laser (for example at 635 nm) is coupled into the highly refractive, wave-guiding tantalum pentoxide layer with the aid of the first coupling grating structured as a relief grating in the carrier substrate according to the invention and conducted there until it is coupled out again on the second grating strip.
- Fluorescent molecules bound to the measuring areas (spots) are excited to fluoresce along the path of the light conduction of the guided light in the evanescent field (on the surface of the tantalum pentoxide film).
- a MALDI matrix is again applied, as described under example ld), and the carrier substrate modified in this way is then analyzed in a MALDI measuring arrangement by mass spectrometry.
- FIG. 1 shows the MALDI mass spectrum (positive ions) of the peptide melittin (Img / mL in H 2 O dist.)
- a carrier substrate consisting of 150 nm tantalum pentoxide on AF45 glass.
- Sinapic acid saturated solution in 50% acetonitrile, 0.1% trifluoroacetic acid
- the time delay (“delay time”) between the laser-induced deodorization step and the application of the acceleration voltage of the MALDI time-of-flight tube was 100 nsec.
- the mass calibration (m / z) of the MALDI measuring arrangement was used as a carrier substrate for a “normal” gold plate the (m / z) values measured with the optically transparent carrier substrate according to the invention changed slightly.
- FIG. 2 shows a measurement of the same sample with a delay time increased to 800 nsec.
- the signals of the sample matrix in the range of small (m / z) values, completely disappear under these conditions, and a higher spectral resolution in the form of a reduced peak width is observed.
- FIG. 3 shows the MALDI mass spectrum (positive ions) of the peptide melittin (Img / mL in H 2 O dist.) On the gold surface of a conventional carrier substrate.
- a MALDI matrix in which the peptide is embedded by mixing the solutions was used, sinapic acid (saturated solution in 50% acetonitrile, 0.1% trifluoroacetic acid). The delay time was 100 nsec.
- the mass calibration (mz) of the MALDI measuring arrangement for a "normal" gold plate was used as the carrier substrate. As expected, the measured (m / z) value of 2848 agrees well with the literature value.
- the mass spectrum is of a similar quality to the spectrum generated in FIG. 1 on a metal oxide surface.
- FIG. 4 shows a MALDI mass spectrum (positive ions) from the range of reference spots, which by applying BSA solution in buffer (for passivation of non-specific, free binding sites) with bovine serum albumin, BSA, which is non-binding for an analyte, is diluted 1:10 in phosphate salt.
- Buffer solution PBS / 10
- Sinapic acid saturated solution in 50% acetonitrile, 0.1% trifluoroacetic acid
- the delay time was 100 nsec.
- the mass calibration (m / z) of the MALDI measuring arrangement for a "normal" gold plate was used as the carrier substrate. Taking into account an expected shift in the measured absolute (m / z) values due to the calibration for another carrier material, the measured spectrum corresponds to the signals characteristic of BSA.
- FIG. 5 shows a section of the spectrum from FIG. 4 for the (m / z) range from 10,000 to 20,000 (corresponding to FIG. 6).
- FIG. 6 shows a MALDI mass spectrum (positive ions) from the range of the measuring ranges (spots) for the detection of human interleukin 4 (h-IL 4) after carrying out the assay: anti-h-IL 4 antibodies were found on the metal oxide surface of a carrier substrate according to the invention, consisting of a tantalum pentoxide layer on AF45 glass, immobilized in discrete measurement areas (spots). After passivating free, non-specific binding sites on the metal oxide surface, the carrier substrate surface was incubated for one hour with a solution of h-IL 4 (1 ⁇ g / ml) as the analyte to be detected in buffer (PBS / 10), then with buffer and subsequently with water washed.
- a carrier substrate according to the invention consisting of a tantalum pentoxide layer on AF45 glass, immobilized in discrete measurement areas (spots).
- the carrier substrate surface was incubated for one hour with a solution of h-IL 4 (1
- the matrix was then applied with sinapic acid (saturated solution in 50% acetonitrile, 0.1% trifluoroacetic acid). The delay time was 100 nsec.
- the mass calibration (m / z) of the MALDI measuring arrangement for a "normal" gold plate was used as the carrier substrate. Taking into account an expected shift in the measured absolute (m / z) values due to the calibration for another carrier material, the measured peak at approximately (m / z) corresponding to 15 kDa corresponds to a signal of hH 4 that may be expected at this point. The signal at around 13 kDa is due to an unknown component that is frequently observed for BSA samples.
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plasma & Fusion (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH22962001 | 2001-12-13 | ||
CH229601 | 2001-12-13 | ||
PCT/EP2002/013312 WO2003050517A1 (en) | 2001-12-13 | 2002-11-26 | Optically transparent substrate for a maldi measuring system and the use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1454127A1 true EP1454127A1 (en) | 2004-09-08 |
Family
ID=4568440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02804574A Withdrawn EP1454127A1 (en) | 2001-12-13 | 2002-11-26 | Optically transparent substrate for a maldi measuring system and the use thereof |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1454127A1 (en) |
AU (1) | AU2002357547A1 (en) |
WO (1) | WO2003050517A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006114249A1 (en) * | 2005-04-26 | 2006-11-02 | Bayer Technology Services Gmbh | Novel equipment and method for coating substrates for analyte detection by way of an affinity assay method |
US20140151548A1 (en) * | 2011-07-08 | 2014-06-05 | Mitsuru Shindo | Matrix for maldi mass spectrometry and maldimass spectrometry method |
CN102866132B (en) * | 2012-09-27 | 2014-10-29 | 广州高通生物技术有限公司 | Chip, production method, application of chip and drug screening method |
CN110108780B (en) * | 2019-05-15 | 2020-06-05 | 浙江大学 | Application of 3-hydrazinobenzoic acid-derivatized glucan in MALDI-TOF-MS (matrix-assisted laser Desorption-time of flight-Mass Spectrometry) |
DE102021105327B3 (en) | 2021-03-05 | 2022-05-12 | Bruker Daltonics GmbH & Co. KG | Desorption ion source with post-desorption ionization in transmission geometry |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1287360A2 (en) * | 2000-06-02 | 2003-03-05 | Zeptosens AG | Kit and method for determining a plurality of analytes |
ES2300358T3 (en) * | 2000-09-05 | 2008-06-16 | Bayer Technology Services Gmbh | PROCEDURE FOR THE PRECIPITATION OF MONOCAPAS AND MULTIPLE LAYERS OF ORGANOPHOSPHORIC AND ORGANOPOSPHONIC ACIDS AND THEIR SALTS, AS WELL AS THEIR USE. |
-
2002
- 2002-11-26 EP EP02804574A patent/EP1454127A1/en not_active Withdrawn
- 2002-11-26 AU AU2002357547A patent/AU2002357547A1/en not_active Abandoned
- 2002-11-26 WO PCT/EP2002/013312 patent/WO2003050517A1/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO03050517A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003050517A1 (en) | 2003-06-19 |
AU2002357547A1 (en) | 2003-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1274986B1 (en) | Device and method for determining multiple analytes | |
EP1556695B1 (en) | Analytical platform and identification method with analytes, which are to be identified in a sample optionally after fractionation and which serve as immobilized specific binding partners | |
DE19725050C2 (en) | Arrangement for the detection of biochemical or chemical substances by means of fluorescent light excitation and method for their production | |
DE112005001895B4 (en) | Methods and systems for the detection of biomolecular bonding using terahertz radiation | |
WO2001092870A2 (en) | Kit and method for determining a plurality of analytes | |
WO2000075644A9 (en) | Sensor platform and method for analysing multiple analytes | |
EP1941276A1 (en) | Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof | |
WO2001055691A2 (en) | Waveguide plate and sensor platforms based thereon, arrangements of sample containers and detection methods | |
DE10012793C2 (en) | Sensor element for optical detection of chemical or biochemical analytes | |
WO2002040998A2 (en) | Kit and method for determining multiple analytes | |
EP1506403A2 (en) | Kit zur assay-entwicklung und für serien-analysen | |
EP1057008A1 (en) | Method and device for measuring luminescence | |
EP1257809A1 (en) | Spr sensor and spr sensor arrangement | |
EP1272829A1 (en) | Grid-waveguide structure for reinforcing an excitation field and use thereof | |
DE10126152A1 (en) | Spatially resolved ellipsometry method for the quantitative and / or qualitative determination of sample changes, biochip and measuring arrangement | |
WO2002046756A1 (en) | Kit and method for multi-analyte determination with arrangements for the positionally resolved referencing of stimulating light intensity | |
WO2004023142A1 (en) | Analytical platform and detection method with analytes which are to be detected in a sample in the form of immobilized specific binding partners | |
EP0872735B1 (en) | Process for the application of reagent spots | |
EP1807699B1 (en) | Structured copolymer supports for use in spectrometry or spectroscopy | |
EP1454127A1 (en) | Optically transparent substrate for a maldi measuring system and the use thereof | |
EP1024363A2 (en) | Quantitative determination of analytes in a heterogeneous system | |
DE10210737A1 (en) | Single-channel multi-color correlation analysis | |
WO1999054497A1 (en) | Method and device for determining the concentration, adsorption and binding kinetics and equilibrium and binding constants of molecules by luminescence measurements | |
EP0784794A1 (en) | Bonding matrix and an analysing device for the simultaneous analysis of various analytes | |
EP2112501A1 (en) | Method and device for measuring luminescence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040630 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
19U | Interruption of proceedings before grant |
Effective date: 20041103 |
|
19W | Proceedings resumed before grant after interruption of proceedings |
Effective date: 20060703 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BAYER TECHNOLOGY SERVICES GMBH |
|
17Q | First examination report despatched |
Effective date: 20091111 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100323 |